Stress overdrive is central to the onset and proliferation of many neuropsychiatric disorders. The only way to break this loop is to counteract stress overdrive in brain signaling. TCAP works to counteract this Stress Feedback Loop at the cellular level in the brain.
Tapping into a cellular-level system in the brain responsible for stress mediation, teneurin c-terminal associated peptides (TCAPs), have the potential to become first-in-class pharmaceutical agents addressing a variety of unmet clinical needs.
TCAP, our lead compound, will enter the clinic in 2022, with multiple potential indications. This TCAP platform will address many neuropsychiatric disorders and other neurodegenerative diseases that are impacted by the stress response system of the brain
© 2022 Protagenic Therapeutics, Inc.
Built by Techtegic
